Expression of MDM2 mRNA, MDM2, P53 and P16 Proteins in Urothelial Lesions in the View of the WHO 4(th) Edition Guidelines as a Molecular Insight towards Personalized Medicine

AIM: Here we imposed a multimarker molecular panel composed of P53, MDM2 protein & mRNA & P16 with the identification of sensitive and specific cut offs among the Egyptian urothelial carcinomas bilharzial or not emphasize the pathological and molecular classifications, pathways and prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammam, Olfat, Magdy, Mona, Badawy, Mohamed, Osili, Khalid Al, Kholy, Amr El, LeitHy, Tarek El
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2017
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591584/
https://www.ncbi.nlm.nih.gov/pubmed/28932295
http://dx.doi.org/10.3889/oamjms.2017.100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591584/
https://www.ncbi.nlm.nih.gov/pubmed/28932295
http://dx.doi.org/10.3889/oamjms.2017.100

Ejemplares similares